PROSPECTUS2017

16/52

Professor Shuhei YAMAGUCHI[Basic Idea] Education and research, and medical service are conducted to equip students with a sense of culture and ethics from an international viewpoint, and cultivate in them the spirit of scientific inquiry, of developing medical and nursing sciences, and consequently making a contribution to the development of the community and the welfare of humanity.[Educational Goal]The educational goal is to produce doctors and nurses who are able to meet the needs of the times by developing in the students a sense of culture and ethics and the spirit of scientific inquiry as well as a humanistic orientation which will enable them to maintain the utmost respect for human life.[History]Shimane Medical University was founded in 1975 and has sent more than 3,000 outstanding physicians to medical facilities all over Japan. In 1999, the School of Nursing was established to educate and train nurses in this growing field. Shimane Medical University was merged into Shimane University on October 1, 2003 and became the Faculty of Medicine of Shimane University. Our campus is located in Izumo City and is separate from other facilities located in Matsue. It consists of almost 300 academic staffs and almost 850 undergraduate students.The Faculty of Medicine has 45 departments in the School of Medicine and 3 departments in the School of Nursing. The undergraduate course for the School of Medicine lasts 6 years and that of the School of Nursing lasts 4 years.We accept international students with a clear vision in their academic research and their own future. We provide advanced lectures in every academic area with a focus on basic and clinical medicine. Please contact us!URL:http://www.med.shimane-u.ac.jp/ (Japanese)Welcome to the Izumo campus of Shimane University. The Faculty of Medicine, composed of the School of Medicine and School of Nursing, is located in Izumo, the second largest city in Shimane Prefecture. About 1,000 students are studying medicine and nursing here. In addition, we have more than 25 foreign students and researchers from 5 different countries. Our campus has various well-organized laboratories and facilities that are utilized for medical and biological research projects. We also have a highly equipped medical center where a number of clinical research projects are ongoing, as we develop new medical devices and techniques. Foreign students and researchers can observe research activities and are encouraged to participate in these projects.The Izumo area is strongly connected to the establishment of ancient Japan with many interesting historical and cultural places to visit. For example, Izumo-Taisha shrine, where you can feel the Japanese spirit, is one of the oldest and most famous shrines in Japan. And the nearby Iwami Ginzan Silver Mine is a World Heritage Site (UNESCO) surrounded by beautiful mountains. Our sincere hope is that many foreign visitors will join us to enjoy academic and cultural activities in and around the Izumo Campus of Shimane University.Research for pancreatic carcinomaPancreatic carcinoma is a highly lethal cancer. More than 90% of patients die within 5 years of their diagnosis and 75% of patients die within the first year. The mortality rate in Shimane Prefecture is above the national average.The immune system attacks foreign invaders in our body, but it doesn’t always recognize cancer cells as enemies. A monoclonal antibody (mAb) is a laboratory-produced molecule that mimics the antibody our body naturally produces as part of our immune system's response to foreign invaders. mAb can be directed to attach to certain parts of a cancer cell surface. mAb circulates throughout the body until it finds and attaches to the cancer cell. Once attached, mAb can recruit other parts of the immune system to destroy the cancer cells. mAb also can deliver anti-cancer drugs directly to the cancer cells. These drugs only damage the cancer cells, leaving the surrounding healthy cells undamaged.We generated mAbs against the cell surface of human pancreatic cancer cell line MIA PaCa-2. In a living pancreatic cancer xenograft mouse model, one of these mAbs demonstrated a tumor-targeting capability and the mAb-labeled liposome containing anti-pancreatic cancer drug inhibited primary tumor growth. We will make a number of monoclonal antibody drugs to treat pancreatic cancer.15Message from DeanInternational Admission PolicyFaculty of Medicine